These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 39203855)
1. Umbrella Review on the Relationship between Vitamin D Levels and Cancer. Schömann-Finck M; Reichrath J Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203855 [TBL] [Abstract][Full Text] [Related]
3. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237 [TBL] [Abstract][Full Text] [Related]
4. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study. Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127 [TBL] [Abstract][Full Text] [Related]
5. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study. Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges. Mondul AM; Weinstein SJ; Layne TM; Albanes D Epidemiol Rev; 2017 Jan; 39(1):28-48. PubMed ID: 28486651 [TBL] [Abstract][Full Text] [Related]
7. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer. Wong YY; Hyde Z; McCaul KA; Yeap BB; Golledge J; Hankey GJ; Flicker L PLoS One; 2014; 9(6):e99954. PubMed ID: 24949795 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina. Aguirre M; Manzano N; Salas Y; Angel M; Díaz-Couselo FA; Zylberman M Arch Osteoporos; 2016; 11():4. PubMed ID: 26732091 [TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842 [TBL] [Abstract][Full Text] [Related]
10. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Giovannucci E Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450 [TBL] [Abstract][Full Text] [Related]
11. The role of vitamin D in cancer prevention. Garland CF; Garland FC; Gorham ED; Lipkin M; Newmark H; Mohr SB; Holick MF Am J Public Health; 2006 Feb; 96(2):252-61. PubMed ID: 16380576 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D and cancer incidence in the Harvard cohorts. Giovannucci E Ann Epidemiol; 2009 Feb; 19(2):84-8. PubMed ID: 18291673 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study. Pazdiora P; Svobodova S; Fuchsova R; Kucera R; Prazakova M; Vrzalova J; Narsanska A; Strakova M; Treskova I; Pecen L; Treska V; Holubec L; Pesek M; Finek J; Topolcan O Anticancer Res; 2011 Oct; 31(10):3619-21. PubMed ID: 21965787 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D and cancer: an overview on epidemiological studies. Ordóñez Mena JM; Brenner H Adv Exp Med Biol; 2014; 810():17-32. PubMed ID: 25207358 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms and cancer. Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361 [TBL] [Abstract][Full Text] [Related]
17. Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Lagunova Z; Porojnicu AC; Grant WB; Bruland Ø; Moan JE Mol Nutr Food Res; 2010 Aug; 54(8):1127-33. PubMed ID: 20512788 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D status and cancer incidence and mortality. Shui I; Giovannucci E Adv Exp Med Biol; 2014; 810():33-51. PubMed ID: 25207359 [TBL] [Abstract][Full Text] [Related]
19. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Jiang X; Dimou NL; Al-Dabhani K; Lewis SJ; Martin RM; Haycock PC; Gunter MJ; Key TJ; Eeles RA; Muir K; Neal D; Giles GG; Giovannucci EL; Stampfer M; Pierce BL; Schildkraut JM; Warren Andersen S; Thompson D; Zheng W; Kraft P; Tsilidis KK; Int J Epidemiol; 2019 Oct; 48(5):1416-1424. PubMed ID: 30597039 [TBL] [Abstract][Full Text] [Related]
20. Association between circulating vitamin D, the Taq1 vitamin D receptor gene polymorphism and colorectal cancer risk among Jordanians. Atoum MF; Tchoporyan MN Asian Pac J Cancer Prev; 2014; 15(17):7337-41. PubMed ID: 25227839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]